Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome
about
Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye diseaseCornea and ocular surface disease: application of cutting-edge optometric researchDesign of a superior cytokine antagonist for topical ophthalmic useEstablishing PAX6 as a biomarker to detect early loss of ocular phenotype in human patients with Sjögren's syndromePax6 downregulation mediates abnormal lineage commitment of the ocular surface epithelium in aqueous-deficient dry eye diseaseTear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture.Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye.IL-1β promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-κB- and AP-1-dependent pathways.Dry eye disease: an immune-mediated ocular surface disorder.Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.New agents for treating dry eye syndrome.Targeting IL-1 in Sjögren's syndrome.Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions.Towards a dynamic customised therapy for ocular surface dysfunctions.Macrophages: important players in primary Sjögren's syndrome?[Testosterone reduces the expression of keratinization-promoting genes in murine Meibomian glands].Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms.Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
P2860
Q24563932-9153BF41-C052-45EE-A5A7-767564F2AF91Q27010492-FE9E1E04-1AE2-4F4E-BA4A-04AC201CBCE1Q27676526-CBF67140-3745-4279-BBD6-99322B9B4C8BQ34473772-04A02718-2302-4EA4-A500-B51A5650FB03Q35021717-0847F4DA-E77D-4371-B0EF-A1C4E40797AFQ35570793-458E4491-B2D0-4408-8EC8-4AC933BB64C9Q36204121-59AF1416-2964-4474-932D-35C3600042B1Q36665694-E0530F05-11B9-4F12-85DB-3825CD533E5DQ36916372-A591334D-B69D-4D7C-A3DB-FA4ECCE94DC7Q37050342-81AF64E4-D0AD-4015-B96C-0A5367EE7A19Q37195776-54E11747-585A-4B43-8565-E652F644BC0DQ38058002-CD2DB974-4D10-4EA2-B409-F818DA3F74B5Q38074174-2BDD75EB-61D7-4ABE-9101-19B4C8F23FE5Q38076460-1C95F6C2-1F17-4297-AF23-704A979A9B46Q38098900-5C9C148B-9BB9-4545-A0E0-2C80A7BFE8CAQ38197286-147C0C3B-4A33-43C5-BAF6-81389598EE98Q38493622-89041E6D-BEB2-45A9-BABB-0EE8698E02CFQ39173291-96E0975F-C9F3-4C8B-B4DB-71C9C94C686EQ41677137-5DA9437B-0D2F-45BC-87F0-0D59B0A361A5
P2860
Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@ast
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@en
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@nl
type
label
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@ast
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@en
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@nl
prefLabel
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@ast
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@en
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@nl
P2093
P2860
P1476
Interleukin-1 as a phenotypic ...... surface in Sjögren's syndrome
@en
P2093
Ahmad F Bahrami
Karina Nikulina
Lisa B Noble
Marianne Gallup
Nancy A McNamara
Stanislav Lazarev
Ying-Ting Chen
P2860
P304
P356
10.2353/AJPATH.2010.100227
P407
P577
2010-08-09T00:00:00Z